Jason Bednar Analyst PerformanceSr. Research Analyst at Piper SandlerJason Bednar is a stock analyst at Piper Sandler in the healthcare sector, covering 21 publicly traded companies. Over the past year, Jason Bednar has issued 49 stock ratings, including buy and hold recommendations. While full access to Jason Bednar's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Jason Bednar's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access to unlock analyst rankings MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings117 Last 6 YearsBuy Recommendations65.18% 73 Buy RatingsCompanies Covered21 Unique Companies Ratings Distribution112RatingsDistribution of strong buy, buy, hold, and sell ratings by Jason Bednar.RatingPercentageCount Strong Buy0.0%0 ratings Buy65.2%73 ratings Hold34.8%39 ratings Sell0.0%0 ratingsOut of 112 total stock ratings issued by Jason Bednar at Piper Sandler, the majority (65.2%) have been Buy recommendations, followed by 34.8% Hold.Best & Worst CallsBest Call000.0%FOCLMar 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%LUNGMay 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ71.4% of companies on NASDAQ15 companiesNYSE28.6% of companies on NYSE6 companiesJason Bednar, an analyst at Piper Sandler, currently covers 21 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageHealthcare21 companies100.0%Jason Bednar of Piper Sandler specializes in stock coverage within the Healthcare sector.Coverage IndustriesIndustryPercentageHEALTHCARE EQUIPMENT & SUPPLIES19 companies90.5%LIFE SCIENCES TOOLS & SERVICES1 company4.8%HEALTHCARE PROVIDERS & SERVICES1 company4.8% About Jason BednarJason Bednar is a managing director and senior research analyst at Piper Sandler focused on the medical technology sector. Prior to joining Piper Sandler in 2020, he spent more than 11 years in medical technology equity research at Robert W. Baird & Co. Bednar holds a Master of Business Administration degree from the University of Chicago Booth School of Business and a bachelor of science degree in finance from Marquette University. Bednar is also a CFA Charterholder. Follow on LinkedIn Jason Bednar's Ratings History at Piper Sandler Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter More filters Fewer filters Done 0 Results Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsKRMDKORU Medical Systems11/11/2026Reiterated Rating$3.31$4.50Neutral$0.0000.00% ROIICUIICU Medical11/6/2026Boost Price Target$167.65$200.00Overweight$0.0000.00% ROIBDXBecton, Dickinson and Company11/6/2026Boost Price Target$213.05$200.00Neutral$0.0000.00% ROISOLVSolventum11/6/2026Reiterated Rating$91.42$110.00Overweight$0.0000.00% ROIALGNAlign Technology10/21/2026Lower Price Target$152.24$205.00Overweight$0.0000.00% ROIALGNAlign Technology10/21/2026Lower Price Target$152.43$205.00Overweight$0.0000.00% ROICOOCooper Companies10/15/2026Reiterated Rating$56.78Neutral$0.0000.00% ROIXRAYDENTSPLY SIRONA10/9/2026Lower Price Target$8.78$12.00Neutral$0.0000.00% ROINVSTEnvista10/9/2026Lower Price Target$22.76$26.00Neutral$0.0000.00% ROINVSTEnvista9/18/2026Reiterated Rating$23.42$28.00Neutral$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. COOCooper Companies9/10/2026Downgrade$63.48$59.00Neutral$0.0000.00% ROISHCSotera Health9/8/2026Reiterated Rating$18.74$25.00Overweight$0.0000.00% ROIBDXBecton, Dickinson and Company8/7/2026Boost Price Target$175.87$175.00Neutral$0.0000.00% ROISTESTERIS8/7/2026Reiterated Rating$236.67$275.00Overweight$0.0000.00% ROISHCSotera Health8/7/2026Reiterated Rating$18.84$25.00Overweight$0.0000.00% ROIICUIICU Medical8/7/2026Boost Price Target$183.36$195.00Overweight$0.0000.00% ROITFXTeleflex8/7/2026Reiterated Rating$135.17$169.00Overweight$0.0000.00% ROISOLVSolventum8/6/2026Boost Price Target$83.51$105.00Overweight$0.0000.00% ROINVSTEnvista8/6/2026Reiterated Rating$27.93$28.00Neutral$0.0000.00% ROIMMSIMerit Medical Systems7/31/2026Boost Price Target$83.35$106.00Overweight$0.0000.00% ROIGEHCGE HealthCare Technologies7/29/2026Reiterated Rating$71.34Buy$0.0000.00% ROIXRAYDENTSPLY SIRONA7/29/2026Boost Price Target$13.49$14.00Neutral$0.0000.00% ROINVSTEnvista7/29/2026Boost Price Target$27.00$26.00Neutral$0.0000.00% ROIHSICHenry Schein7/29/2026Boost Price Target$85.95$95.00Overweight$0.0000.00% ROIMMSIMerit Medical Systems7/10/2026Reiterated Rating$72.33Overweight$0.0000.00% ROICOOCooper Companies6/1/2026Set Price Target$60.47$86.00Overweight$0.0000.00% ROIDRTSAlpha Tau Medical5/19/2026Boost Price Target$10.03$8.00Neutral$0.0000.00% ROISHCSotera Health5/6/2026Reiterated Rating$15.78$22.00Overweight$0.0000.00% ROIGEHCGE HealthCare Technologies4/30/2026Lower Price Target$60.46$74.00$0.0000.00% ROIALGNAlign Technology4/21/2026Boost Price Target$191.66$235.00Overweight$0.0000.00% ROISOLVSolventum4/17/2026Lower Price Target$68.82$92.00Overweight$0.0000.00% ROIMMSIMerit Medical Systems4/17/2026Lower Price Target$70.10$96.00Overweight$0.0000.00% ROIICUIICU Medical4/17/2026Lower Price Target$126.04$163.00Overweight$0.0000.00% ROIGEHCGE HealthCare Technologies4/17/2026Lower Price Target$73.20$88.00Overweight$0.0000.00% ROIBDXBecton, Dickinson and Company4/17/2026Lower Price Target$154.89$159.00Neutral$0.0000.00% ROIDRTSAlpha Tau Medical3/4/2026Downgrade$7.07$5.00Neutral$0.0000.00% ROIICUIICU Medical2/20/2026Boost Price Target$149.74$178.00Overweight$0.0000.00% ROIMMSIMerit Medical Systems2/18/2026Lower Price Target$81.59$106.00Overweight$0.0000.00% ROIMASIMasimo2/17/2026Downgrade$174.50$180.00Hold$0.0000.00% ROIBDXBecton, Dickinson and Company2/10/2026Reiterated Rating$207.31$170.00Neutral$0.0000.00% ROIToday's free pick (on me) (Ad)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one lesser known company. With plans filed for 1,000,000 new satellites, that licensing fee could scale dramatically. Analyst Dylan says the stock could move by December 8th.Get today's free pick before December 8th.NVSTEnvista2/6/2026Reiterated Rating$24.81$25.00Neutral$0.0000.00% ROIALGNAlign Technology2/5/2026Boost Price Target$161.30$220.00Overweight$0.0000.00% ROINVSTEnvista1/30/2026Boost Price Target$23.38$21.00Neutral$0.0000.00% ROIGEHCGE HealthCare Technologies1/30/2026Boost Price Target$78.78$94.00Overweight$0.0000.00% ROIBDXBecton, Dickinson and Company1/28/2026Boost Price Target$203.41$205.00Neutral$0.0000.00% ROIMDLNMedline1/12/2026Initiated Coverage$40.52$50.00Overweight$0.0000.00% ROISHCSotera Health1/9/2026Upgrade$18.81$24.00Overweight$0.0000.00% ROISOLVSolventum12/17/2025Reiterated Rating$80.72Overweight$0.0000.00% ROICOOCooper Companies12/5/2025Reiterated Rating$77.03$94.00Overweight$0.0000.00% ROIBDXBecton, Dickinson and Company11/7/2025Lower Price Target$177.44$190.00Neutral$000.0000.00% ROIICUIICU Medical11/7/2025Boost Price Target$129.67$172.00Overweight$000.0000.00% ROISOLVSolventum11/7/2025Boost Price Target$66.25$98.00Overweight$00.0000.00% ROISHCSotera Health11/5/2025Boost Price Target$16.07$17.00Neutral$00.0000.00% ROIMMSIMerit Medical Systems10/31/2025Reiterated Rating$87.85$109.00Overweight$00.0000.00% ROIALGNAlign Technology10/30/2025Reiterated Rating$147.68$200.00Overweight$000.0000.00% ROIALGNAlign Technology10/23/2025Reiterated Rating$136.02$190.00Overweight$000.0000.00% ROIICUIICU Medical9/10/2025Boost Price Target$130.57$153.00Overweight$000.0000.00% ROICOOCooper Companies8/28/2025Lower Price Target$64.90$83.00Overweight$00.0000.00% ROIICUIICU Medical8/15/2025Initiated Coverage$111.90$145.00Overweight$000.0000.00% ROISOLVSolventum8/8/2025Reiterated Rating$71.99$94.00Overweight$00.0000.00% ROIBDXBecton, Dickinson and Company8/8/2025Reiterated Rating$187.49$200.00Neutral$000.0000.00% ROIMASIMasimo8/6/2025Boost Price Target$142.87$210.00Overweight$0.0000.00% ROINVSTEnvista8/1/2025Boost Price Target$18.89$19.00Neutral$00.0000.00% ROILUNGPulmonx7/31/2025Downgrade$3.15$2.50Neutral$0.0000.00% ROIMMSIMerit Medical Systems7/31/2025Lower Price Target$83.89$105.00Overweight$00.0000.00% ROIALGNAlign Technology7/31/2025Lower Price Target$140.24$190.00Overweight$000.0000.00% ROINVCRNovoCure6/27/2025Reiterated Rating$17.51$34.00Overweight$00.0000.00% ROICOOCooper Companies5/30/2025Reiterated Rating$67.82$105.00Overweight$00.0000.00% ROIMMSIMerit Medical Systems5/23/2025Reiterated Rating$94.49$110.00Overweight$00.0000.00% ROISOLVSolventum5/19/2025Upgrade$74.08$87.00Overweight$00.0000.00% ROIFOCLFocalTherics5/15/2025Downgrade$1.72Neutral$0.0000.00% ROISOLVSolventum5/9/2025Lower Price Target$69.71$78.00Neutral$00.0000.00% ROIKRMDKORU Medical Systems5/8/2025Lower Price Target$3.25$3.50Neutral$0.0000.00% ROIMASIMasimo5/7/2025Reiterated Rating$149.59$200.00Overweight$000.0000.00% ROIBDXBecton, Dickinson and Company5/2/2025Downgrade$169.56$185.00Neutral$000.0000.00% ROILUNGPulmonx5/1/2025Reiterated Rating$4.14$9.00Overweight$0.0000.00% ROIALGNAlign Technology5/1/2025Reiterated Rating$184.87$250.00Overweight$000.0000.00% ROIXRAYDENTSPLY SIRONA4/30/2025Lower Price Target$13.71$16.00Neutral$00.0000.00% ROIHSICHenry Schein4/30/2025Lower Price Target$64.71$77.00Overweight$00.0000.00% ROINVSTEnvista4/30/2025Lower Price Target$15.66$17.00Neutral$00.0000.00% ROISOLVSolventum4/30/2025Lower Price Target$65.66$80.00Neutral$00.0000.00% ROIMMSIMerit Medical Systems4/23/2025Lower Price Target$93.66$112.00Overweight$00.0000.00% ROIBDXBecton, Dickinson and Company4/23/2025Lower Price Target$203.92$260.00Overweight$000.0000.00% ROISHCSotera Health4/23/2025Lower Price Target$10.93$13.00Neutral$00.0000.00% ROINVCRNovoCure4/23/2025Lower Price Target$17.42$34.00Overweight$00.0000.00% ROIFOCLFocalTherics3/28/2025Lower Price Target$2.13$4.50Overweight$0.0000.00% ROIALGNAlign Technology3/18/2025Reiterated Rating$163.91$235.00Overweight$000.0000.00% ROICOOCooper Companies3/7/2025Reiterated Rating$84.04$115.00Overweight$00.0000.00% ROISOLVSolventum2/28/2025Boost Price Target$83.46$84.00Neutral$00.0000.00% ROIMASIMasimo2/26/2025Boost Price Target$187.59$215.00Overweight$000.0000.00% ROII'm handing you this one free (Ad)Elon Musk doesn't own the chip powering every Tesla, every Starlink dish, and every AI satellite he builds. He licenses it from one overlooked company. That supplier just got a major catalyst. Musk filed to launch 1,000,000 satellites, a move analyst Dylan believes could drive a 100X bigger bill for this chipmaker starting December 8th.See today's free stock pick before the December 8th deadline hereKRMDKORU Medical Systems2/14/2025Reiterated Rating$4.75$4.50Neutral$0.0000.00% ROIALGNAlign Technology2/6/2025Lower Price Target$216.36$270.00Overweight$000.0000.00% ROISTESTERIS2/3/2025Boost Price Target$218.55$265.00Overweight$000.0000.00% ROINVSTEnvista2/3/2025Boost Price Target$20.26$18.00Neutral$00.0000.00% ROIMMSIMerit Medical Systems1/29/2025Reiterated Rating$110.00$116.00Overweight$00.0000.00% ROIBDXBecton, Dickinson and Company1/28/2025Boost Price Target$248.55$280.00Overweight$000.0000.00% ROIMMSIMerit Medical Systems1/21/2025Boost Price Target$102.90$114.00Overweight$00.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerDeutsche BankBMO Capital Markets Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
